Investors & Media

News

HomeInvestors & MediaNews

[메디파나뉴스] 기술 이전에 흑자 전환까지… "의학적 미개척 분야로 글로벌 도전장"
2022-12-16ablbio
list
PREV
ABL Bio receives near-term milestone for ABL301
NEXT
ABL Bio enters the phase 1 expansion part of global clinical trials by applying for phase 1 of ABL503 in Korea

ABL Bio

메뉴닫기